
                                SEQUENCE LISTING

<110> Foundation Medicine, Inc.

<120> SYSTEMS AND METHODS FOR EVALUATING TUMOR FRACTION

<130> 19710-20065.40

<140> PCT/US2021/38547
<141> 2021-06-22

<160> 1

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 150
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<220> 
<221> misc_feature   
<222> 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30,
31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44,
45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58,
59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72,
73
<223> n = A,T,C or G

<220> 
<221> misc_feature   
<222> 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88,
89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102,
103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114,
115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125
<223> n = A,T,C or G

<220> 
<221> misc_feature   
<222> 126, 127, 128, 129, 130, 131, 132, 133, 134, 135
<223> n = A,T,C or G

<400> 1
atcgcaccag cgtgtnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 60
nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 120
nnnnnnnnnn nnnnncactg cggctcctca                                  150
